Literature DB >> 11054718

Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma.

T Saito1, Y Oda, A Sakamoto, S Tamiya, N Kinukawa, K Hayashi, Y Iwamoto, M Tsuneyoshi.   

Abstract

This study addresses the immunohistochemical expression of the E-cadherin and catenin families and mutations of the beta-catenin gene detected by PCR-SSCP in synovial sarcoma. Immunohistochemical analysis was performed for 72 cases, with follow-up data available on 62. The prognostic value of the expression of these proteins was evaluated. Reduced immunoreactivity for E-cadherin and alpha-catenin was significantly correlated with a poor survival rate (p=0.0040 and 0.0053, respectively). According to multivariate analysis, low AJC stage (stages I and II: p<0.0001), the preservation of alpha-catenin expression (p=0.0001), and a low necrotic rate (<50%: p=0.0139) were independent favourable prognostic factors. Widespread aberrant staining of beta-catenin protein within cytoplasm and/or nuclei was observed in 28 cases (38.9%) and was significantly correlated with poor survival (p=0.0122). In addition, there was a trend towards a correlation between widespread aberrant staining of beta-catenin and the MIB-1 labelling index (p=0.0535). Mutational analysis of exon 3 of the beta-catenin gene was performed for 49 cases. Nucleotide sequencing analysis revealed that four (8.2%) contained point mutations (three in codon 32, GAC to TAC; one in codon 37, TCT to TTT). Survival data were available for three out of four cases with beta-catenin mutations; two of these patients died within 1 year (died of disease at 6 and 11 months, respectively). These results suggest that E-cadherin and alpha-catenin undertake important roles as intercellular adhesion molecules; their preserved expression is associated with a better overall survival rate in synovial sarcoma and may have prognostic value. Abnormal levels of beta-catenin, with or without mutation, could contribute to the development and progression of synovial sarcoma, through increasing the proliferative activity of the tumour cells. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054718     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  21 in total

1.  Morphogenesis of chicken liver: identification of localized growth zones and the role of beta-catenin/Wnt in size regulation.

Authors:  Sanong Suksaweang; Chih-Min Lin; Ting-Xin Jiang; Michael W Hughes; Randall B Widelitz; Cheng-Ming Chuong
Journal:  Dev Biol       Date:  2004-02-01       Impact factor: 3.582

2.  Expression and localization of E-cadherin and β-catenin in uterine carcinosarcoma.

Authors:  Izumi Nishimura; Yoshihiro Ohishi; Yoshinao Oda; Junji Kishimoto; Masafumi Yasunaga; Emi Okuma; Hiroaki Kobayashi; Norio Wake; Masazumi Tsuneyoshi
Journal:  Virchows Arch       Date:  2010-11-03       Impact factor: 4.064

3.  Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.

Authors:  Jared J Barrott; Benjamin E Illum; Huifeng Jin; Matthew L Hedberg; Yanliang Wang; Allie Grossmann; Malay Haldar; Mario R Capecchi; Kevin B Jones
Journal:  J Clin Invest       Date:  2017-11-20       Impact factor: 14.808

4.  E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.

Authors:  T Saito; Y Oda; K Sugimachi; K Kawaguchi; S Tamiya; K Tanaka; S Matsuda; A Sakamoto; Y Iwamoto; M Tsuneyoshi
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

5.  Expression of E-cadherin, beta-catenin and topoisomerase IIalpha in leiomyosarcomas.

Authors:  Pinelopi N Gogou; Anna Batistatou; Emilios E Pakos; Nikiforos Apostolikas; Dimitrios Stefanou; Pericles G Tsekeris
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

6.  Biphasic synovial sarcoma of the abdominal wall.

Authors:  Jesús Vera; María-Dolores García; Miguel Marigil; Manuel Abascal; Jose-Ignacio Lopez; Luis Ligorred
Journal:  Virchows Arch       Date:  2006-07-20       Impact factor: 4.064

Review 7.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

8.  Targeting the Wnt pathway in synovial sarcoma models.

Authors:  Whitney Barham; Andrea L Frump; Taylor P Sherrill; Christina B Garcia; Kenyi Saito-Diaz; Michael N VanSaun; Barbara Fingleton; Linda Gleaves; Darren Orton; Mario R Capecchi; Timothy S Blackwell; Ethan Lee; Fiona Yull; Josiane E Eid
Journal:  Cancer Discov       Date:  2013-08-06       Impact factor: 39.397

9.  The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.

Authors:  Jianming Tang; Huijuan Shi; Hui Li; Tiantian Zhen; Yu Dong; Fenfen Zhang; Yang Yang; Anjia Han
Journal:  Tumour Biol       Date:  2016-02-02

Review 10.  The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.

Authors:  Tsuyoshi Saito
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.